Immunosuppressive mechanism

Immunosuppressive mechanisms" is not a specific molecule or receptor but rather refers to a broad set of biological processes and pathways by which the immune system's activity is reduced or modulated. These mechanisms are mediated by various regulatory cells (such as regulatory T cells, regulatory B cells, myeloid-derived suppressor cells) and involve multiple molecular mediators including inhibitory cytokines (e.g., interleukin 10 [IL-10], transforming growth factor beta [TGF-beta]), inhibitory receptors (e.g., CTLA-4, PD-1), metabolic reprogramming, and other soluble factors[1][2][4]. These processes play essential roles in maintaining self-tolerance and preventing excessive inflammation but can also be exploited by tumors or pathogens to evade immune surveillance[1][4]. Because "immunosuppressive mechanisms" does not refer to a single defined target but rather an array of cellular and molecular interactions, it is not considered a canonical therapeutic target such as a receptor or enzyme. Instead, individual components within these pathways—such as PD-L1/PD-1 axis—are targeted therapeutically in diseases like cancer[4]. Note: The entry "Immunosuppressive mechanisms" is too broad and non-specific for structured drug-target information; it should be replaced with the name of an individual molecule (e.g., "Programmed cell death protein 1") or cell type for accurate mapping.

Other names

ImmunosuppressionMechanisms of immunosuppressionImmune suppression mechanisms